Your browser is no longer supported. Please, upgrade your browser.
LABD Direxion Daily S&P Biotech Bear 3X Shares daily Stock Chart
Direxion Daily S&P Biotech Bear 3X Shares
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week9.75%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-4.62%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-24.05%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-42.15%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-46.38%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range10.70 - 28.82 Perf YTD0.24%
Dividend0.16 P/FCF- EPS past 5Y- ROI- 52W High-53.26% Beta-
Dividend %1.29% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low25.89% ATR0.76
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)62.10 Volatility5.01% 5.50%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.77 Prev Close12.38
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume4.06M Price13.47
Recom- SMA209.99% SMA509.72% SMA200-27.09% Volume5,416,533 Change8.80%
Feb-10-20 09:39AM  3 Leveraged Healthcare ETFs Soaring This Month Benzinga
Oct-09-19 10:10AM  6 Best Leveraged Inverse ETFs of Past Week Zacks
Jun-04-19 10:43AM  Day Trading With Leveraged ETFs Investopedia -8.24%
May-23-19 10:10AM  5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2 Zacks
Apr-09-19 02:26PM  In the Age of Algorithms +5.40%
09:25AM  Big Moves In Leveraged Biotech ETFs Benzinga
Jan-14-19 10:05AM  This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders Benzinga +6.56%
Dec-21-18 10:58AM  7 Inverse ETFs That Soared More Than 70% in Q4 Zacks +13.32%
Nov-13-18 03:57PM  The Time Could Be Right For This Biotech ETF Benzinga
Oct-09-18 11:59AM  7 Leveraged/Inverse ETFs Off to a Strong Start in October Zacks
Jul-18-18 12:27PM  Exploring The Leveraged ETF Trade Heading Into Earnings Season Benzinga
Mar-28-18 11:43AM  For Now, Traders Endorse Biotech Rally Benzinga
Feb-28-18 04:30PM  Direxion Announces Reverse Splits of Five ETFs PR Newswire +5.17%
Nov-29-17 04:46PM  Short Interest And Leveraged ETFs Benzinga
Nov-15-17 01:18PM  How venture philanthropy is helping to find a diabetes cure Yahoo Finance Video
Nov-14-17 03:49PM  Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate Benzinga
02:13PM  GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader Yahoo Finance Video
10:33AM  Yellen, Draghi, Carney and Kuroda met in Frankfurt todayhere's what went down Yahoo Finance Video
Nov-13-17 01:45PM  The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader Yahoo Finance Video
Nov-10-17 11:05AM  Nvidia and Intel are set to be long-term market leaders Yahoo Finance Video
10:55AM  Stocks have bigger problems than tax reform Yahoo Finance Video
Nov-09-17 05:20PM  3 signs the bulls are still kicking Yahoo Finance Video
Nov-06-17 11:10AM  Why the Broadcom bid for Qualcomm may end in a proxy battle Yahoo Finance Video
Aug-31-17 04:37PM  A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers Benzinga
Jul-27-17 02:43PM  4 Things To Know Before Trading A Leveraged ETF Benzinga
Jul-13-17 11:00AM  This Market Action Is Once Again Sluggish
Jun-30-17 11:38AM  Fourth of July Fireworks May Be at Hand, but Today's Action Is a Dud
Jun-28-17 10:45AM  The Market Is Going Green, Yet Again
Feb-17-17 01:40PM  Biotech 2017: 4 Ideas for A Stockpicker's Year at
Jan-11-17 03:14PM  What pharma investors ought to do after Donald Trump fires a salvo at MarketWatch
Jan-02-17 01:00AM  NVDA, LABD, TWM: Rev Shark's Views
01:00AM  NVDA, LABD, TWM: Rev Shark's Views
Dec-28-16 11:24AM  Dip Buying Wanes at Year's End
11:24AM  Dip Buying Wanes at Year's End
Dec-08-16 10:34AM  How Will Trumps Take on the ACA Affect Healthcare Stocks? Market Realist
10:34AM  How Will Trumps Take on the ACA Affect Healthcare Stocks?
Nov-08-16 09:34AM  Which Sectors to Invest in If Donald Trump Wins
Oct-17-16 10:10AM  ETFs to Play as Biotech Juggles Election & Earnings
Oct-14-16 03:26PM  Can Biotech Stocks Stay Trendy?
Sep-29-16 02:00PM  LABD Rallies as Mylan, Biotechs Slump (LABD) Investopedia
02:00PM  LABD Rallies as Mylan, Biotechs Slump (LABD) at Investopedia
Sep-27-16 03:21PM  Loving LABU: A Leveraged Biotech ETF On A Torrid Pace Benzinga
Sep-06-16 10:43AM  Technicals, Politics Clash for Biotech ETFs ETF Trends
Aug-25-16 02:14PM  Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks ETF Trends
06:52AM  The Active Traders Guide To Hillary Clinton's Rhetoric Benzinga
Aug-04-16 01:46PM  Biotech Rally Stokes Activity In Leveraged ETFs Benzinga
Jun-22-16 02:07PM  Traders Get It Right (Sort Of) With Leveraged Biotech ETFs
Jun-09-16 10:06AM  Will New SEC Rules Hurt Triple Leveraged ETFs?
Jun-07-16 12:33AM  Biotech Bounce: Sizzle Or Fizzle?
Jun-03-16 12:05PM  How to Play the Biotech Rally (IBB,GILD,LABD) at Investopedia
Jun-01-16 08:30AM  Finally A Biotech ETF Bounce?
May-16-16 08:00AM  Resisting the Temptation of Biotech ETFs
Apr-01-16 09:59AM  Are These ETFs Making You An April Fool?
Mar-16-16 02:05PM  4 stocks to watch at MarketWatch
Feb-29-16 01:45PM  Top 10 ETFs Of 2016 To Date
Feb-12-16 08:11AM  This Little Nugget Of An ETF Is Delivering Astounding Returns
Feb-11-16 01:43PM  This Biotech ETF Is Setting A Blistering Pace
10:33AM  Barely Legal ETFs Bring Triple the Returns for China Bears at TheStreet
Jan-20-16 04:28PM  One Russia ETF To Look At Right Now
Jan-12-16 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear
Dec-03-15 02:17PM  A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
Oct-28-15 03:12PM  Traders Get Adventurous With Leveraged Biotech ETFs
02:22PM  Is There A Bubble In Leveraged ETFs? at
Oct-06-15 01:16PM  Leveraged ETF Rebalancing: It's Not As Bad As It Seems
Oct-02-15 02:53PM  Breaking Down Biotech ETFs With Leverage
Sep-30-15 09:30AM  The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechn
Sep-29-15 10:17AM  How to Short Biotechnology Stocks with ETFs
Sep-28-15 03:57PM  Wild Ride For Leveraged Biotech ETFs Continues
Sep-25-15 12:08PM  Guide to Inverse & Leveraged Biotech ETF Investing
11:14AM  Should You Avoid Biotech Stocks Right Now? at Investopedia
Sep-23-15 10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
Sep-22-15 02:34PM  Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet
Sep-16-15 07:18AM  They're Heeere: Leveraged Cybersecurity ETFs
Aug-20-15 03:28PM  A Bad Sign For Biotech Bulls
Aug-19-15 01:20PM  4 New Leveraged ETFs Right For The Times
Aug-07-15 02:31PM  A Bad Week For Biotech Was Great For This ETF
Jul-28-15 07:30AM  How to Get Bearish on Biotech With ETFs
Jul-16-15 11:00AM  Impressive Bull Run in Biotech ETFs Causes Some to Take Pause
Jul-02-15 10:53AM  Are Bears About to Burst the Biotech Bubble? at Investopedia
Jun-23-15 12:30PM  More Triple-Leveraged Biotech ETFs Come to Town
09:00AM  Mess With the Leveraged Biotech Bull ETF and get the Horns
Jun-15-15 03:05PM  Volatility in Healthcare ETFs Ahead of Supreme Courts Obamacare Ruling
Jun-09-15 12:08PM  Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Jun-05-15 12:53PM  Preparing for Biotech ETF Retrenchment
Jun-02-15 08:00AM  New Leveraged Biotech ETF off to a Fast Start
May-28-15 11:47AM  Back in the Lab: Triple-Leveraged Biotech ETFs are Here
08:30AM  Direxion Investments Launches Four Leveraged ETFs for Active Traders PR Newswire
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.